Biomarin Pharmaceutical (BMRN) Finished Goods (2010 - 2021)
Biomarin Pharmaceutical (BMRN) reported Finished Goods of $261.64 million for Q3 2021, down 20.8% from $330.31 million a year earlier but up 3.3% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Finished Goods (2010 - 2021) Analysis & Trends
At the end of FY2020, Biomarin Pharmaceutical posted Finished Goods of $313.59 million, up 22.6% from FY2019.
- Finished Goods has increased for ten consecutive years, with a five-year compound annual growth rate of 33.0% (FY2015 to FY2020).
- By year, Finished Goods came in at $255.86 million in FY2019 (+13.6%), $225.19 million in FY2018 (+17.8%), $191.22 million in FY2017 (+40.5%) and $136.09 million in FY2016 (+80.8%).
- Five-year quarterly Finished Goods spans a low of $129.57 million in Q2 2017 and a high of $330.31 million in Q3 2020.
- Year over year, Finished Goods gained in six of the last eight quarters, with growth averaging 16.9%.
- The high point for year-over-year Finished Goods in five years was Q4 2016 (growth of 80.8%); the low point was Q3 2021 (a decline of 20.8%).
- Per Business Quant data, the three quarters before Q3 2021 came in at $253.3 million (Q2 2021), $279.6 million (Q1 2021) and $313.59 million (Q4 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Biomarin Pharmaceutical | 11.51 Bn | 5.37 Bn | 786.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 261.64 Mn |
| Jun 30, 2021 | 253.30 Mn |
| Mar 31, 2021 | 279.60 Mn |
| Dec 31, 2020 | 313.59 Mn |
| Sep 30, 2020 | 330.31 Mn |
| Jun 30, 2020 | 292.57 Mn |
| Mar 31, 2020 | 251.48 Mn |
| Dec 31, 2019 | 255.86 Mn |
| Sep 30, 2019 | 219.59 Mn |
| Jun 30, 2019 | 208.11 Mn |
| Mar 31, 2019 | 191.47 Mn |
| Dec 31, 2018 | 225.19 Mn |
| Sep 30, 2018 | 210.90 Mn |
| Jun 30, 2018 | 192.45 Mn |
| Mar 31, 2018 | 220.94 Mn |
| Dec 31, 2017 | 191.22 Mn |
| Sep 30, 2017 | 146.20 Mn |
| Jun 30, 2017 | 129.57 Mn |
| Mar 31, 2017 | 129.89 Mn |
| Dec 31, 2016 | 136.09 Mn |
API Access
Biomarin Pharmaceutical Finished Goods API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=finished-goods&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "finished-goods", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=finished-goods&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();